公司动态 - Brenmiller Energy首席运营官Nir Brenmiller将于2024年12月4日11:25 AM EST在Emerging Growth Conference上发表演讲，介绍公司如何通过近期公告加速实现价值至少4.4亿美元的项目管道[2] - Nir Brenmiller将详细阐述公司与美国TUTCO Heating Solutions Group和德国Entelios AG的合作，这些合作将推动德国TES市场到2028年达到29亿美元[3] 技术创新 - Brenmiller的TES技术通过使用碎石将电能转化为可储存的热能，为工业应用提供24/7的可靠性和透明的生产成本，减少对波动性天然气和碳燃料的依赖[4] - 公司与TUTCO的合作结合了TUTCO的电阻加热工程专业知识和Brenmiller的创新TES技术，创造了强大的协同效应，解决了清洁能源生产和存储的挑战[5] - bGen™ ZERO系统通过将低成本的可再生能源转化为可储存的蒸汽、热空气或热水，重新定义了能源生产和存储，特别适用于食品饮料、制药和化工等能源密集型行业[7] 市场潜力 - bGen™ ZERO系统的价值包括：零碳排放、成本效益、24/7运行、可扩展性和灵活性、符合绿色能源指令、热即服务（HaaS）模式以及对难以电气化行业的支持[8][9] - 这些优势帮助公司服务于近5亿美元的项目管道，并得到其在以色列Dimona的先进gigafactory的支持，这是全球首个专门用于TES生产的工厂[10] 行业认可 - Brenmiller Energy在TES技术领域被公认为行业最佳选择，获得了多项荣誉，包括入选《时代》杂志2023年最佳绿色能源发明、欧洲投资银行AdVenture Debt Summit的创新冠军、BloombergNEF的BNEF Pioneers决赛选手以及2023年能源存储奖的多项赞誉[11] ESG承诺 - Brenmiller致力于环境、社会和治理（ESG）原则，其bGen™技术旨在提供可扩展的可再生能源解决方案，支持全球脱碳目标，并在2023-2024年ESG报告中强调了其在难以电气化行业减少排放的努力[12] 行业趋势 - 随着清洁能源指令和碳减排政策的推动，Brenmiller Energy的竞争优势和系统多功能性在可持续工业能源领域树立了新的标杆，其技术、合作伙伴关系、欧盟关系和ESG一致性加速了这一趋势[13]

The Cooper Companies, Inc.’s (COO) fourth-quarter fiscal 2024 results are scheduled to be released on Dec. 5, after the closing bell.In the last reported quarter, the company’s earnings beat the Zacks Consensus Estimate by 5.49%. Its earnings beat estimates in three of the trailing four quarters and met once, delivering an average surprise of 3.87%.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Q4 EstimatesThe Zacks Consensus Estimate for revenues is pegged at $1.03 billion, indica ...

Wall Street analysts expect The Cooper Companies (COO) to post quarterly earnings of $1 per share in its upcoming report, which indicates a year-over-year increase of 14.9%. Revenues are expected to be $1.03 billion, up 10.8% from the year-ago quarter.Over the last 30 days, there has been a downward revision of 1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this tim ...

分组1 - 分析师在寻找生育行业的投资机会 但尚未找到具有吸引力的长期选项 [1] - 此前关注的公司PGNY近期表现疲软 且缺乏全球业务布局 [1] - 分析师目前专注于研究被激进做空机构盯上的公司 这些公司通常被市场低估 且具有不对称的风险/回报特征 [1] - 对这些公司的研究需要特别关注会计 法律 监管细节以及管理层的判断和叙述 [1] 分组2 - 分析师持有COO公司的多头仓位 包括股票 期权或其他衍生品 [2] - 文章内容仅代表分析师个人观点 未获得任何公司报酬 [2]

CALGARY, AB, Nov. 27, 2024 /PRNewswire/ - Canadian Pacific Kansas City (TSX: CP) (NYSE: CP) (CPKC) President and Chief Executive Officer Keith Creel and Executive Vice-President and Chief Operating Officer Mark Redd will now address the 2024 UBS Global Industrials and Transportation Conference on Dec. 4, 2024, at 9:40 a.m. ET.CPKC will provide access to the live audio webcast at investor.cpkcr.com. A replay will also be available following the conclusion of the event.About Canadian Pacific Kansas CityWith i ...

CALGARY, AB, Nov. 19, 2024 /PRNewswire/ - Canadian Pacific Kansas City (TSX: CP) (NYSE: CP) (CPKC) President and Chief Executive Officer Keith Creel and Executive Vice-President and Chief Operating Officer Mark Redd will address the 2024 UBS Global Industrials and Transportation Conference on Dec. 3, 2024, at 8:50 a.m. ET.CPKC will provide access to the live audio webcast at investor.cpkcr.com. A replay will also be available following the conclusion of the event.About Canadian Pacific Kansas CityWith its g ...

公司人员任命相关 - Abivax宣布任命Mark Stenhouse为董事会观察员和顾问 [1] - Mark Stenhouse在生物制药行业拥有30多年经验 曾在Prometheus Biosciences担任首席运营官该公司2023年被默克以108亿美元收购 此前在AbbVie工作超25年 在Exact Sciences担任行政领导职务 拥有查尔斯顿学院工商管理学士学位 [2][3] - Abivax首席执行官Marc de Garidel表示欢迎Mark Stenhouse 期望其经验能支持公司走向商业化并加强产品线 Mark Stenhouse表示对Abivax的obefazimod临床情况印象深刻 期待与公司团队合作推进关键里程碑 [4] 公司及药物相关 - Abivax是临床阶段生物技术公司 专注于开发利用身体自然调节机制稳定慢性炎症疾病患者免疫反应的疗法 总部位于法国和美国 其主要候选药物obefazimod正在进行治疗中重度活动性溃疡性结肠炎的3期临床试验 [6] - Obefazimod是一种口服小分子 可能增强miR - 124的表达 溃疡性结肠炎的2期临床试验产生积极数据 已启动关键的全球3期临床试验计划 2022年10月美国已招募首位患者 克罗恩病的2b期临床试验正在进行 2024年10月招募首位患者 正在探索溃疡性结肠炎联合治疗机会 [5]

SAN RAMON, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today announced it will report fourth quarter and full year 2024 financial results on Thursday, December 5, 2024, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 2026064. A simultaneous audio webcast and subsequent replay can be accessed at http://inves ...

Brenmiller Energy COO Talks With Nicole Brodie About Project Pipeline and Near-Term Value Drivers Wednesday October 23, 2024October 22, 2024 9:15 AM EDT | Source: Hawk Point Media Group.This on-demand interview highlights the groundwork completed, the inherent value of signed agreements, and the work behind generating an estimated $440 million project pipeline. Mr. Brenmiller also fields investor questions regarding the company's current valuation and what's being done to increase shareholder ...

文章核心观点 - 分析师看好科勒公司(COO)的前景,认为其在接触镜市场持续获得市场份额增长[1] - 分析师自身持有COO股票的长期权益头寸[1] 公司表现 - 科勒公司近几个季度在接触镜市场持续获得市场份额增长[1] - 科勒公司正在拓展女性健康业务[1] 行业分析 无相关内容